Main > ONCOLOGY (**) > Multiple Myeloma>New Diag>ASCT Yes+ > Treatment > Co: USA. J. DaratumuMAb+

---

Co: USA. J. DaratumuMAb+'s subsections
(*) USA Approval Date: 2019. 09.26.
+Bortezomib+Thalidomide+Dexamethaso
Company
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 2
Patent>UpDate: 2019. 12.24.
TradeMark
TradeMark Web-Site

Co: USA. J. DaratumuMAb+'s products
This section has no products